FIVE PRIME THERAPEUTICS INC's ticker is FPRX and the CUSIP is 33830X104. A total of 129 filers reported holding FIVE PRIME THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is 5.15 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $1,148,000 | +50.7% | 85,663 | +4.5% | 0.01% | +33.3% |
| Q4 2018 | $762,000 | -13.0% | 81,956 | +30.2% | 0.01% | 0.0% |
| Q3 2018 | $876,000 | +8.4% | 62,961 | +23.2% | 0.01% | +20.0% |
| Q2 2018 | $808,000 | +3.1% | 51,090 | +12.0% | 0.01% | -16.7% |
| Q1 2018 | $784,000 | +11.5% | 45,616 | +42.3% | 0.01% | +20.0% |
| Q4 2017 | $703,000 | -39.3% | 32,058 | +13.2% | 0.01% | -37.5% |
| Q3 2017 | $1,159,000 | +48.2% | 28,330 | +9.1% | 0.01% | +60.0% |
| Q2 2017 | $782,000 | -11.6% | 25,966 | +6.1% | 0.01% | -16.7% |
| Q1 2017 | $885,000 | -51.1% | 24,468 | -32.2% | 0.01% | -53.8% |
| Q4 2016 | $1,808,000 | -23.1% | 36,085 | -19.5% | 0.01% | -31.6% |
| Q3 2016 | $2,352,000 | +9.4% | 44,803 | -13.8% | 0.02% | 0.0% |
| Q2 2016 | $2,150,000 | +298.1% | 51,994 | +291.3% | 0.02% | +216.7% |
| Q1 2016 | $540,000 | – | 13,289 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 6,338,678 | $238,778,000 | 8.95% |
| One Fin Capital Management LP | 440,000 | $16,575,000 | 6.37% |
| COMMODORE CAPITAL LP | 361,344 | $13,612,000 | 5.42% |
| Chicago Capital Management, LLC | 295,864 | $11,145,000 | 5.19% |
| Kellner Capital, LLC | 226,876 | $8,546,000 | 3.10% |
| HARVEST MANAGEMENT LLC | 97,500 | $3,673,000 | 2.20% |
| Rock Springs Capital Management LP | 2,660,822 | $100,233,000 | 2.19% |
| ALPINE ASSOCIATES MANAGEMENT INC. | 2,007,700 | $75,630,000 | 2.05% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 198,278 | $7,469,000 | 1.95% |
| GARDNER LEWIS ASSET MANAGEMENT L P | 236,565 | $8,911,000 | 1.60% |